Category: Pharmacology, Toxicology and Pharmaceutics RSS
Zuranolone was approved for postpartum depression, not major depressive disorder
How expedited drug approval processes may compromise regulatory safety standards
Rivaroxaban controversy linked to synthetic certainty
How a faulty blood-clotting monitor undermined evidence for a widely recommended stroke drug
Meloxicam approval in cats is questioned over kidney risk and missing trial data
Examining safety concerns and conflicts of interest in feline pain management
FAERS data show post-marketing adverse event patterns with casimersen
Safety patterns of casimersen revealed through real-world adverse event reports
